Survival rates among COVID-19 patients treated with high flow nasal oxygen therapy with a do-not-intubate-order: an observational study
I. Smesseim (Amsterdam, Netherlands), B. Atasever (Haarlem, Netherlands), L. Hessels (Alkmaar, Netherlands), D. Korevaar (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), B. Goorhuis (Amsterdam, Netherlands), E. Nossent (Amsterdam, Netherlands), K. Mooij-Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands)
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Smesseim (Amsterdam, Netherlands), B. Atasever (Haarlem, Netherlands), L. Hessels (Alkmaar, Netherlands), D. Korevaar (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), B. Goorhuis (Amsterdam, Netherlands), E. Nossent (Amsterdam, Netherlands), K. Mooij-Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands). Survival rates among COVID-19 patients treated with high flow nasal oxygen therapy with a do-not-intubate-order: an observational study. 1762
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
High Flow nasal OXygen therapy in high risk patients of hypoxia undergoing diagnostic BRONCHOscopy (HiFOXy-BRONCHO):a prospective, randomized, controlled study Source: International Congress 2018 – New tools for managing respiratory failure Year: 2018
Electromyographic swallowing study during high flow oxygen therapy compared with low flow oxygen therapy in post-extubated patients Source: International Congress 2019 – Recent developments in intensive care unit medicine Year: 2019
COPD patients’ experience of long-term domestic oxygen-enriched nasal high flow treatment: A qualitative study. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020
Survival in COPD patients under long-term oxygen therapy Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation Year: 2019
Survival in patients on long-term oxygen therapy (LTOT) Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009
Long-term oxygen therapy: compliance of patients Source: Eur Respir J 2001; 18: Suppl. 33, 390s Year: 2001
Survival after intensive care for COPD exacerbation in patients with and without long-term oxygen therapy: a nationwide cohort study Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019
Relative survival of patients with COPD on long-term oxygen therapy Source: Eur Respir J 2001; 18: Suppl. 33, 275s Year: 2001
The association of the oxygen saturation level at the time of hospitalization with comorbidities and subsequent changes in blood biomarkers in patients with COVID-19 in Russia: observational study results. Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021
First and second waves results of COVID-19 patients treated with non-invasive respiratory therapies outside the ICU: unicentric, observational study Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond Year: 2021
Transtracheal oxygen therapy as an effective treatment in patients suffering from severe hypoxemia and with high flow oxygen requirement: Description of two cases Source: Annual Congress 2011 - A little bit of everything: interventional pneumology Year: 2011
Effects of N-acetylcysteine treatment during long-term oxygen therapy (LTOT) in COPD patients. An open parallel-group study Source: Eur Respir J 2001; 18: Suppl. 33, 58s Year: 2001
Survival and quality of life of patients treated by long term noninvasive ventilation (NIV). Results from a prospective cohort study. Source: International Congress 2017 – Latest insights into chronic care Year: 2017
Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy. Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019
Comparison of continuous flow versus demand oxygen delivery systems in COPD patients: a systematic review and meta-analysis Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018
Predictors of success in COPD exacerbation treated with non-invasive mechanical ventilation (NIMV): a 5-year prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 278s Year: 2002
Long-term nasal high flow treatment with oxygen in COPD - exacerbations, admissions and mortality Source: International Congress 2017 – Best abstracts in physical activity and management of COPD Year: 2017
High-flow oxygen therapy vs non invasive ventilation: a prospective randomized cross-over physiological study of alveolar recruitment in acute respiratory failure Source: International Congress 2019 – Current trends in noninvasive ventilation for acute respiratory failure Year: 2019
A retrospective study of the use of ROX index to predict failure in patients receiving CPAP for COVID-19 Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond Year: 2021
Early non-invasive ventilation versus conventional oxygen therapy in immunocompromised patients with respiratory failure: a meta-analysis Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation Year: 2017